Pay in 4 interest-free payments of $5.15 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
ROS-generating, pH-responsive and highly tunable reduced graphene oxide-embedded microbeads showing intrinsic anticancer properties and multi-drug co-delivery capacity for combination cancer therapy
Peptide supporters have asked the FDA to consider the seven peptides under review this week for various medical conditions, including ulcerative colitis, migraines and opioid addiction
(Those were the days!) In 1966, Blue Cross Blue Shield companies were the only insurers who had the claims processing capability and computing power to administer the new Medicare program
Increasing the antimicrobial activity of nisinbased lantibiotics against gram-negative pathogens
US$ 29.88
US$ 24.79
US$ 28.68
.png)
US$ 24.78
US$ 22.82
